A pesquisa do papilomavírus humano (HPV) pela reação de hibridização in situ realizada no Núcleo de Patologia Quantitativa do Centro de Patologia do Instituto Adolfo Lutz

Autores

  • Leonardo José Tadeu de Araújo Instituto Adolfo Lutz
  • Karolina Rosa Fernandes Beraldo Instituto Adolfo Lutz
  • Daniela Soares Damaceno Instituto Adolfo Lutz
  • Suely Nonogaki Instituto Adolfo Lutz
  • Neuza Kasumi Shirata Instituto Adolfo Lutz
  • Lidia Midori Kimura Instituto Adolfo Lutz
  • Marina Oyafuso Instituto Adolfo Lutz
  • Celso di Loreto Instituto Adolfo Lutz
  • Juliana Mariotti Guerra Instituto Adolfo Lutz

DOI:

https://doi.org/10.57148/bepa.2019.v.16.37679

Palavras-chave:

.

Resumo

.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Egawa N, Doorbar J. The

low-risk papillomaviruses. Virus

res. 2017;231:119-27.

Lorenzi AT, Syrjänen KJ, LongattoFilho A. Human papillomavirus (HPV)

screening and cervical cancer burden. A Brazilian perspective. Virology

journal. 2015 Dec;12(1):112.

Doorbar J, Egawa N, Griffin H, Kranjec

C, Murakami I. Human papillomavirus

molecular biology and disease association.

Rev. med. virol. 2015;25:2-23.

Oliveira CM, Levi JE. The Biological

Impact of Genomic Diversity in

Cervical Cancer Development.

Acta cytol. 2016; 60(6):513-17.

Van Ham MAPC, Melchers WJG,

Hanselaar AGJM, Bekkers RLM, Boonstra

H, Massuger LFAG. Fluctuations

in prevalence of cervical human

papillomavirus in women frequently

sampled during a single menstrual cycle.

Br. j. cancer. 2002; 87(4):373-76.

International Agency for Research on

Cancer. Working Group on the Evaluation

of Carcinogenic Risks to Humans.

Human Papillomaviruses. Lyon, France:

World Health Organization; 1995.

IARC Monographs on the Evaluation of

Carcinogenic Risks to Humans.;64.

Souza N, Melo V, Castro L. Diagnóstico

da infecção pelo HPV em lesões do

colo do útero em mulheres HIV+:

acuidade da histopatologia. Rev. bras.

ginecol. obstet. 21;23(6):355-61.

Tavassoli F, Deville P. World Health

Organization Classification of Tumours.

Pathology & Genetics. Tumours of the

Breast and Female Genital Organs. Lyon,

France: IARC Press. p. 233-6, 2003.

Carvalho JJM, Oyakawa N. I

Consenso Brasileiro de HPV. São

Paulo: BG Cultural; 2000.

Downes MR. Review of in situ

and invasive penile squamous cell

carcinoma and associated non-neoplastic

dermatological conditions. J. clin.

pathol. 2015; 68:333-40.

Linhares AC, Villa LL. Vacinas contra

rotavírus e papilomavírus humano (HPV).

J Pediatr. 2006 Jul;82(3):25-34.

Modesto VL, Gottesman L. Sexually

transmitted diseases and anal

manifestations of AIDS. Surg. clin.

North America. 1994;74(6):1433-64.

Zaravinos A, Mammas IN, Sourvinos

G, Spandidos DA. Molecular detection

methods of human papillomavirus (HPV).

Int. j. biol. markers. 2009; 24(4):215-22.

Ming Guo, Gong Y, Deavers M et al.

Evaluation of a Commercialized In Situ

Hybridization Assay for Detecting Human

Papillomavirus DNA in Tissue Specimens

from Patients with Cervical Intraepithelial

Neoplasia and Cervical Carcinoma. J.

clin. microbiol. 2008; 46(1):274-80.

Steinau M, Onyekwuluje JM, Scarbrough

MZ et al. Performance of Commercial

Reverse Line Blot Assays for Human

Papillomavirus Genotyping. J. clin.

microbial. 2012; 50(5):1539-44.

Iftner T, Villa LL. Chapter 12:

Human Papillomavirus Technologies

current technology for human

papillomavirus dna detection of genital

infections. v.31, p.80-8, 2003.

Siadat-Pajouh M, Ayscue Ah,

Periasamy AHB. Introduction of a

fast and sensitive fluorescent in situ

hybridization method for single-copy

detection of human papillomavirus

(HPV) genome. J. histochem.

cytochem. 1994; 42(11):1503-12.

Vidal FCB, Nascimento MDSB, Ferraro

CTL, Brito LM. Análise crítica dos métodos

moleculares. Femina. 2012; 40:263-7.

Uhlig K, Earley A, Lamont J, Dahabreh IJ,

Avendano EE, Cowan JMFS. Fluorescence

in situ hybridization (FISH) or other

in situ hybridization (ISH) testing of uterine cervical cells to predict precancer

and cancer. Rockville (MD): Agency

for Healthcare Research and Quality.

Technology Assessment Report; 2013.

Bagarelli LB, Oliani AH. Tipagem e

estado físico de papilomavírus humano

por hibridização in situ em lesões

intra-epiteliais do colo uterino. Human

Papillomavirus Typing and Physical

State by in situ Hybridization in Uterine

Cervix Intraepithelial Lesions. Trabalhos

Originais. 2004; 26(261):59-64.

Montag M, Blankenstein TJ, Shabani N,

Bruning A, Mylonas I. Evaluation of two

commercialised in situ hybridisation

assays for detecting HPV-DNA in

formalin-fixed, paraffin-embedded

tissue. Arch. gynecol. obstet.

; 284(4):999 1005.

Warford A. In situ hybridisation:

technologies and their application to

understanding disease. Prog. histochem.

cytochem. 2016; 50(4):37-48.

Laabidi B, Ben Rejeb S, Bani A, Mansouri

N, Lamine O, Bouzaini A et al. Human

papillomavirus detection using in situ

hybridization and correlations with

histological and cytological findings.

Med. mal. infect. 2016; 46(7):380-84.

Mendez-Pena JE, Sadow PM, Nose

V, Hoang MP. A chromogenic in situ

hybridization assay with clinical

automated platform is a sensitive

method in detecting high-risk human

papillomavirus in squamous cell

carcinoma. Hum. pathol. 2017; 63:184-9.

Kimura LM, Shirata NK, Nonogaki

S, Guerra JM, Oyafuso MS, Menezes

Y, et al. Padronização do protocolo de

hibridização in situ cromogênica (CISH)

para detecção de HPV de alto e baixo

risco com a utilização da sonda comercial

marcada com digoxigenina. BEPA,

Bol. epidemiol. paul. 2017; 14:1-11.

Molijn A, Jenkins D, Chen W, Zhang

X, Pirog E, Enqi W, et al. The complex

relationship between human papillomavirus

and cervical adenocarcinoma. Int.

j. cancer. 2016; 138(2):409-16.

Tyring Sk. Human papillomavirus

infections: epidemiology, pathogenesis,

and host immune response. J. Am.

Acad. Dermatol. 2000; 43(1):18-26.

Birner P, Bachtiary B, Dreier B et al.

Signal-Amplified Colorimetric In Situ

Hybridization for Assessment of Human

Papillomavirus Infection in Cervical

Lesions. Mod. pathol. 2001; 14(7):702-9.

Sarkar FH, Miles BJ, Plieth DHCJ.

Detection of human papillomavirus

in squamous neoplasm of the penis.

J. urol. 1992; 143(2):389-92.

Bezerra AL, Lopes A, Santiago GH et al.

Human papillomavirus as a prognostic

factor in carcinoma of the penis: analysis

of 82 patients treated with amputation

and bilateral lymphadenectomy.

Cancer. 2001; 91(12):2315-21.

Lont AP, Kroon BK, Horenblas S

et al. Presence of high-risk human

papillomavirus DNA in penile carcinoma

predicts favorable outcome in survival.

Int. j. cancer. 2006; 119:1078-73.

Lu B, Viscidi RP, Lee JH, Wu Y, Villa

LL, Lazcano-Ponce E, et al. Human

papillomavirus (HPV) 6, 11, 16, and

seroprevalence is associated with

sexual practice and age: results from

the multinational HPV Infection in Men

Study (HIM Study). Cancer epidemiol.

biomark. prev. 2011; 20(5):990-1002.

Markos A. The presentation of anogenital

cancers as sexually transmissible

infection: a case for vigilance.

Sex. health. 2007; 4(1):79-80.

34. Singhi AD, Westra WH. Comparison of

human papillomavirus in situ hybridizationand p16 immunohistochemistry

in the detection of human

papillomavirus‐associated head

and neck cancer based on a

prospective clinical experience.

Cancer. 2010; 116(9):2166-73.

35. Jitani AK, Raphael V, Mishra J,

Shunyu NB, Khonglah Y, Medhi J.

Analysis of human papilloma virus

/18 DNA and its correlation

with p16 expression in oral cavity

squamous cell carcinoma in NorthEastern India: A chromogenic in-situ

hybridization based study. J Clin

Diagn Res. 2015; 9(8):EC04-EC07.

36. Gómez F, Picazo A, Roldán M,

Corcuera MT, Curiel I, Munoz E,

et al. Labelling pattern obtained by

non-isotopic in situ hybridization as a

prognostic factor in HPV-associated

lesions. J. pathol. 1996: 179(3):272-5.

37. Pirami L, Giache V, Becciolini

A. Analysis of HPV1 6, 18, 3 1,

and 35 DNA in pre-invasive and

invasive lesions of the uterine cervix.

J. clin. pathol. 1997; 50:600-4.

Downloads

Publicado

2022-06-12

Como Citar

1.
Tadeu de Araújo LJ, Rosa Fernandes Beraldo K, Soares Damaceno D, Nonogaki S, Kasumi Shirata N, Midori Kimura L, Oyafuso M, di Loreto C, Mariotti Guerra J. A pesquisa do papilomavírus humano (HPV) pela reação de hibridização in situ realizada no Núcleo de Patologia Quantitativa do Centro de Patologia do Instituto Adolfo Lutz. Bepa [Internet]. 12º de junho de 2022 [citado 25º de maio de 2024];16(184):1-11. Disponível em: https://periodicos.saude.sp.gov.br/BEPA182/article/view/37679

Edição

Seção

Artigo Original

Artigos mais lidos pelo mesmo(s) autor(es)